Literature DB >> 2358681

Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant.

C Ohlén1, J Bastin, H G Ljunggren, L Foster, E Wolpert, G Klein, A R Townsend, K Kärre.   

Abstract

The lymphoma mutant RMA-S escaped graft rejection after transplantation over a minor histocompatibility barrier, whereas it was rejected in H-2 allogeneic mice. The parental control line was rejected in both situations. The mutant, which had been selected against MHC class I molecules retained 5 to 10% of the wild-type H-2Db, Kb, and beta 2-microglobulin expression on the cell surface. It remained sensitive to allo-H-2b CTL in vitro, but was completely resistant to minor histocompatibility antigen-specific, H-2b-restricted CTL. It was equally resistant to other H-2b-restricted responses against internally derived Ag, such as tumor-specific CTL or a CTL clone specific for the influenza virus nucleoprotein. The results indicate a target cell defect that selectively abolishes the sensitivity to H-2-restricted CTL directed against internally processed Ag. This appears sufficient to shift the transplantation response over a minor histocompatibility Ag barrier from rejection to acceptance. There are two possible explanations for the results: 1) a block in the MHC class I-directed pathway for internal Ag processing, and 2) subthreshold H-2/Ag ligand density in relation to triggering requirements of restricted CTL. Regardless of the type of defect, the results demonstrate a difference between allo-H-2-specific and H-2-restricted CTL recognition at the level of the target cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358681

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Exploiting the exploiter: a viral inhibitor stabilizes TAP for cryo-EM.

Authors:  Rutger D Luteijn; Emmanuel J H J Wiertz
Journal:  Nat Struct Mol Biol       Date:  2016-02       Impact factor: 15.369

3.  Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.

Authors:  E Z Wolpert; M Petersson; B J Chambers; J K Sandberg; R Kiessling; H G Ljunggren; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants.

Authors:  G Lombardi; M Matsui; R Moots; G Aichinger; S Sidhu; R Batchelor; J Frelinger; R Lechler
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 5.  The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.

Authors:  Subramaniam Malarkannan
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

6.  Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.

Authors:  K D Smith; D F Epperson; C T Lutz
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response.

Authors:  N P Restifo; F Esquivel; A L Asher; H Stötter; R J Barth; J R Bennink; J J Mulé; J W Yewdell; S A Rosenberg
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

8.  RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.

Authors:  F Esquivel; J Yewdell; J Bennink
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

9.  GD2 oligosaccharide: target for cytotoxic T lymphocytes.

Authors:  X J Zhao; N K Cheung
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

10.  Reconstruction of cell lineage trees in mice.

Authors:  Adam Wasserstrom; Rivka Adar; Gabi Shefer; Dan Frumkin; Shalev Itzkovitz; Tomer Stern; Irena Shur; Lior Zangi; Shai Kaplan; Alon Harmelin; Yair Reisner; Dafna Benayahu; Eldad Tzahor; Eran Segal; Ehud Shapiro
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.